Proteomics

Dataset Information

0

The key roles of PMVK in hepatocarcinogenesis


ABSTRACT: Metabolic reprogramming is a hallmark of cancer and a driver of hepatocellular carcinoma (HCC) initiation and progression. Through metabolic CRISPR screening, we identify phosphomevalonate kinase (PMVK), a critical kinase in the mevalonate pathway, as a key regulator in HCC stemness and lipid metabolism. Mechanistically, PMVK directly phosphorylates the transcription factor SP1 at Thr355, enhancing its DNA-binding affinity to increase transcriptional activity to promote the expression of genes involved in de novo lipid synthesis. Phosphorylated SP1 directly interacts with nuclear SREBP1/2, master factors of lipid biosynthesis, and facilitates the transcription of their target genes. Clinically, elevated levels of PMVK and phospho-SP1 (Thr355) are associated with poor prognosis in HCC patients. Functionally, genetic or pharmacologic inhibition of PMVK or SP1 significantly suppress HCC growth in cell lines, mouse models, and patient-derived organoids. These findings uncover a previously unrecognized PMVK–SP1 ax

ORGANISM(S): Homo Sapiens

SUBMITTER: Fei Xiao  

PROVIDER: PXD072683 | iProX | Mon Jan 05 00:00:00 GMT 2026

REPOSITORIES: iProX

Similar Datasets

2022-12-08 | GSE146049 | GEO
2012-03-28 | E-GEOD-34019 | biostudies-arrayexpress
2012-03-28 | E-GEOD-34018 | biostudies-arrayexpress
2025-11-17 | MTBLS13241 | MetaboLights
2014-09-25 | GSE58382 | GEO
2023-02-01 | MSV000091180 | MassIVE
2026-03-04 | GSE299794 | GEO
2015-09-30 | GSE70979 | GEO
2015-09-30 | GSE70978 | GEO
2012-03-29 | GSE34019 | GEO